Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen's new Spinraza data for earlier use 'pretty amazing,' analyst says
Biogen's new Spinraza data for earlier use 'pretty amazing,' analyst says
Biogen's new Spinraza data for earlier use 'pretty amazing,' analyst says
Submitted by
admin
on October 8, 2018 - 11:37pm
Source:
Fierce Pharma
News Tags:
Biogen
Spinraza
spinal muscular atrophy
SMA
Headline:
Biogen's new Spinraza data for earlier use 'pretty amazing,' analyst says
snippet:
A new interim analysis of presymptomatic spinal muscular atrophy patients treated with Biogen's Spinraza shows that the drug "has the potential to dramatically change the course" of the disease, according to a company executive.
Do Not Allow Advertisers to Use My Personal information